Tenchov, R., Sasso, J. M. & Zhou, Q. A. PEGylated lipid nanoparticle formulations: immunological security and effectivity perspective. Bioconjug. Chem. 34, 941–960 (2023).
Müller, S. S. et al. Biodegradable hyperbranched polyether–lipids with in-chain pH-sensitive linkages. Polym. Chem. 7, 6257–6268 (2016).
Kedmi, R., Ben-Arie, N. & Peer, D. The systemic toxicity of positively charged lipid nanoparticles and the position of Toll-like receptor 4 in immune activation. Biomaterials 31, 6867–6875 (2010).
Huotari, J. & Helenius, A. Endosome maturation. EMBO J. 30, 3481–3500 (2011).
Gao, W., Chan, J. M. & Farokhzad, O. C. pH-Responsive nanoparticles for drug supply. Mol. Pharm. 7, 1913–1920 (2010).
Zhuo, S. et al. pH-sensitive biomaterials for drug supply. Molecules 25, 5649 (2020).
Shin, J., Shum, P. & Thompson, D. H. Acid-triggered launch by way of dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J. Management. Launch 91, 187–200 (2003).
Guo, X. & Szoka, F. C. Steric stabilization of fusogenic liposomes by a low-pH delicate PEG-diortho ester–lipid conjugate. Bioconjug. Chem. 12, 291–300 (2000).
Jayaraman, M. et al. Maximizing the efficiency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Ed. 51, 8529–8533 (2012).
Zhang, Y., Solar, C., Wang, C., Jankovic, Okay. E. & Dong, Y. Lipids and lipid derivatives for RNA supply. Chem. Rev. 121, 12181–12277 (2021).
Roise, J. J. et al. Acid-sensitive surfactants improve the supply of nucleic acids. Mol. Pharm. 19, 67–79 (2022).
Yang, X. et al. Making good medication smarter: the significance of linker chemistry in focused drug supply. Med. Res. Rev. 40, 2682–2713 (2020).
Liu, B. & Thayumanavan, S. S. Substituent results on the pH sensitivity of acetals and ketals and their correlation with encapsulation stability in polymeric nanogels. J. Am. Chem. Soc. 139, 2306–2317 (2017).
Hansch, C., Leo, A. & Taft, R. W. A survey of Hammett substituent constants and resonance and area parameters. Chem. Rev. 91, 165–195 (1991).
Takahata, Y. & Chong, D. P. Estimation of Hammett sigma constants of substituted benzenes via correct density-functional calculation of core–electron binding power shifts. Int. J. Quantum Chem. 103, 509–515 (2005).
Waggoner, L. E., Miyasaki, Okay. F. & Kwon, E. J. Evaluation of PEG-lipid anchor size on lipid nanoparticle pharmacokinetics and exercise in a mouse mannequin of traumatic mind harm. Biomater. Sci. 11, 4238–4253 (2023).
Kim, J. et al. Engineering lipid nanoparticles for enhanced intracellular supply of mRNA via inhalation. ACS Nano 16, 14792–14806 (2022).
Lokugamage, M. P. et al. Optimization of lipid nanoparticles for the supply of nebulized therapeutic mRNA to the lungs. Nat. Biomed. Eng. 5, 1059–1068 (2021).
Coelho, F., Salonen, L. M. & Silva, B. F. B. Hemiacetal-linked pH-sensitive PEG-lipids for non-viral gene supply. N. J. Chem. 46, 15414–15422 (2022).
Fang, Y. et al. Cleavable PEGylation: a technique for overcoming the “PEG dilemma” in environment friendly drug supply. Drug Deliv. 24, 22–32 (2017).
Kozma, G. T., Shimizu, T., Ishida, T. & Szebeni, J. Anti-PEG antibodies: properties, formation, testing and position in adversarial immune reactions to PEGylated nano-biopharmaceuticals. Adv. Drug Deliv. Rev. 154-155, 163–175 (2020).
Wang, H. et al. Polyethylene glycol (PEG)-associated immune responses triggered by clinically related lipid nanoparticles in rats. NPJ Vaccines 8, 169 (2023).
Yanez Arteta, M. et al. Profitable reprogramming of mobile protein manufacturing via mRNA delivered by functionalized lipid nanoparticles. Proc. Natl Acad. Sci. USA 115, E3351–E3360 (2018).
Kilchrist, Okay. V. et al. Gal8 visualization of endosome disruption predicts carrier-mediated biologic drug intracellular bioavailability. ACS Nano 13, 1136–1152 (2019).
Schmiderer, L. et al. Environment friendly and non-toxic biomolecule supply to main human hematopoietic stem cells utilizing nanostraws. Proc. Natl Acad. Sci. USA 117, 21267–21273 (2020).
Levetzow, G. V. et al. Nucleofection, an environment friendly non-viral methodology to switch genes into human hematopoietic stem and progenitor cells. Stem Cells Dev. 15, 278–285 (2006).
Vhora, I., Lalani, R., Bhatt, P., Patil, S. & Misra, A. Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene supply to bone-marrow mesenchymal stem cells for osteoinduction. Int. J. Pharm. 563, 324–336 (2019).
Shi, D., Toyonaga, S. & Anderson, D. G. In vivo RNA supply to hematopoietic stem and progenitor cells by way of focused lipid nanoparticles. Nano Lett. 23, 2938–2944 (2023).
Kumar, V. et al. Shielding of lipid nanoparticles for siRNA supply: impression on physicochemical properties, cytokine induction, and efficacy. Mol. Ther. Nucleic Acids 3, e210 (2014).
Sakurai, Y. et al. Environment friendly siRNA supply by lipid nanoparticles modified with a non-standard macrocyclic peptide for EpCAM-targeting. Mol. Pharm. 14, 3290–3298 (2017).
Chander, N., Basha, G., Yan Cheng, M. H., Witzigmann, D. & Cullis, P. R. Lipid nanoparticle mRNA techniques containing excessive ranges of sphingomyelin engender increased protein expression in hepatic and extra-hepatic tissues. Mol. Ther. Strategies Clin. Dev. 30, 235–245 (2023).
Ruoslahti, E. Mind extracellular matrix. Glycobiology 6, 489–492 (1996).
Dankovich, T. M. et al. Extracellular matrix transforming via endocytosis and resurfacing of Tenascin-R. Nat. Commun. 12, 7129 (2021).
Cheng, Q. et al. Selective organ concentrating on (SORT) nanoparticles for tissue-specific mRNA supply and CRISPR–Cas gene enhancing. Nat. Nanotechnol. 15, 313–320 (2020).
LoPresti, S. T., Arral, M. L., Chaudhary, N. & Whitehead, Okay. A. The alternative of helper lipids with charged options in lipid nanoparticles facilitates focused mRNA supply to the spleen and lungs. J. Management. Launch 345, 819–831 (2022).
Frohlich, E. The position of floor cost in mobile uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 7, 5577–5591 (2012).
Hu, M., Zhou, N., Cai, W. & Xu, H. Lysosomal solute and water transport. J. Cell Biol. 221, e202109133 (2022).
Zahid, M. U., Ma, L., Lim, S. J. & Smith, A. M. Single quantum dot monitoring reveals the impression of nanoparticle floor on intracellular state. Nat. Commun. 9, 1830 (2018).
Pei, Y. et al. Synthesis and bioactivity of readily hydrolysable novel cationic lipids for potential lung supply software of mRNAs. Chem. Phys. Lipids 243, 105178 (2022).
Qiu, M. et al. Lung-selective mRNA supply of artificial lipid nanoparticles for the remedy of pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).
Li, Q. et al. Engineering caveolae-targeted lipid nanoparticles to ship mRNA to the lungs. ACS Chem. Biol. 15, 830–836 (2020).
Landesman-Milo, D. & Peer, D. Toxicity profiling of a number of widespread RNAi-based nanomedicines: a comparative examine. Drug Deliv. Transl. Res. 4, 96–103 (2014).
Sanders, L. M. & Zeisel, S. H. Choline: dietary necessities and position in mind growth. Nutr. In the present day 42, 181–186 (2007).
Gibellini, F. & Smith, T. Okay. The Kennedy pathway—de novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62, 414–428 (2010).
Raghu, G., Nyberg, F. & Morgan, G. The epidemiology of interstitial lung illness and its affiliation with lung most cancers. Br. J. Most cancers 91, S3–S10 (2004).
McAleer, J. P. & Kolls, J. Okay. Directing site visitors IL‐17 and IL‐22 coordinate pulmonary immune protection. Immunol. Rev. 260, 129–144 (2014).
Muhl, H. et al. IL-22 in tissue-protective remedy. Br. J. Pharmacol. 169, 761–771 (2013).
Mizoguchi, A. et al. Medical significance of IL-22 cascade in IBD. J. Gastroenterol. 53, 465–474 (2018).
Hwang, S., Feng, D. & Gao, B. Interleukin-22 acts as a mitochondrial protector. Theranostics 10, 7836–7840 (2020).